🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/12/2018 | 0,5248 USD |
| 14/09/2018 | 0,4580 USD |
| 14/06/2018 | 0,4580 USD |
| 14/03/2018 | 0,4580 USD |
| 14/12/2017 | 0,4580 USD |
| 14/09/2017 | 0,4485 USD |
| 13/06/2017 | 0,4485 USD |
| 13/03/2017 | 0,4485 USD |
| 13/12/2016 | 0,4485 USD |
| 13/09/2016 | 0,4389 USD |
| 13/06/2016 | 0,4389 USD |
| 11/03/2016 | 0,4389 USD |
| 11/12/2015 | 0,4389 USD |
| 11/09/2015 | 0,4294 USD |
| 11/06/2015 | 0,4294 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 27/11/2013 | 47,32 | 47,62 | 47,29 | 47,55 | +0,50% | 0,71% | 12.120.644 |
| 26/11/2013 | 47,39 | 47,47 | 46,91 | 47,31 | -0,16% | 1,19% | 24.040.386 |
| 25/11/2013 | 46,71 | 47,56 | 46,70 | 47,39 | +1,47% | 1,84% | 19.159.641 |
| 22/11/2013 | 46,27 | 46,79 | 46,22 | 46,70 | +0,66% | 1,24% | 14.638.359 |
| 21/11/2013 | 46,01 | 46,47 | 45,95 | 46,39 | +1,02% | 1,12% | 13.453.281 |
| 20/11/2013 | 45,78 | 46,20 | 45,56 | 45,93 | +0,12% | 1,40% | 8.647.991 |
| 19/11/2013 | 45,85 | 45,96 | 45,47 | 45,87 | +0,12% | 1,08% | 8.745.874 |
| 18/11/2013 | 45,84 | 46,05 | 45,59 | 45,81 | -0,12% | 1,00% | 8.310.745 |
| 15/11/2013 | 45,45 | 46,07 | 45,45 | 45,87 | +0,52% | 1,36% | 12.567.092 |
| 14/11/2013 | 45,34 | 45,68 | 45,32 | 45,63 | +1,01% | 0,78% | 11.822.069 |
| 13/11/2013 | 44,60 | 45,20 | 44,51 | 45,17 | -0,53% | 1,54% | 14.836.955 |
| 12/11/2013 | 44,80 | 45,45 | 44,66 | 45,41 | +1,26% | 1,77% | 14.620.229 |
| 11/11/2013 | 44,76 | 44,99 | 44,73 | 44,85 | +0,43% | 0,58% | 7.895.003 |
| 08/11/2013 | 43,83 | 44,72 | 43,76 | 44,66 | +2,14% | 2,20% | 18.260.142 |
| 07/11/2013 | 44,04 | 44,12 | 43,68 | 43,72 | -0,30% | 1,00% | 12.235.819 |
| 06/11/2013 | 43,47 | 43,91 | 43,26 | 43,86 | +1,32% | 1,49% | 12.954.642 |
| 05/11/2013 | 43,50 | 43,68 | 43,24 | 43,28 | -0,79% | 1,01% | 10.920.684 |
| 04/11/2013 | 43,82 | 44,15 | 43,57 | 43,63 | +1,08% | 1,33% | 16.954.020 |
| 01/11/2013 | 42,81 | 43,27 | 42,58 | 43,16 | +0,31% | 1,63% | 21.896.388 |
| 31/10/2013 | 43,23 | 43,38 | 43,02 | 43,02 | -0,33% | 0,82% | 15.713.922 |
| 30/10/2013 | 43,65 | 43,66 | 43,04 | 43,17 | -0,75% | 1,42% | 10.436.508 |
| 29/10/2013 | 43,33 | 43,58 | 43,02 | 43,49 | +0,51% | 1,30% | 16.652.720 |
| 28/10/2013 | 43,48 | 43,72 | 43,14 | 43,27 | -2,56% | 1,34% | 28.607.885 |
| 25/10/2013 | 44,13 | 44,45 | 43,75 | 44,41 | +0,69% | 1,58% | 18.752.912 |
| 24/10/2013 | 44,66 | 44,71 | 44,07 | 44,10 | -0,73% | 1,43% | 11.738.753 |
| 23/10/2013 | 44,47 | 44,58 | 44,35 | 44,43 | +0,19% | 0,52% | 10.113.934 |
| 22/10/2013 | 44,19 | 44,58 | 44,03 | 44,34 | -0,09% | 1,25% | 16.601.892 |
| 21/10/2013 | 44,56 | 44,58 | 43,97 | 44,38 | -0,21% | 1,37% | 17.478.544 |
| 18/10/2013 | 45,20 | 45,28 | 44,34 | 44,48 | -1,06% | 2,07% | 21.622.755 |
| 17/10/2013 | 44,97 | 45,11 | 44,74 | 44,95 | -0,13% | 0,83% | 14.544.668 |